GLP-1 medications are progressing into the mainstream US market and redirecting formulation strategies toward complementary nutrient-dense food and beverage options. This emerging class of products is enhanced with functional ingredients such as specific fibers, bioactives, and micronutrients. These inclusions help sustain satiety, muscle mass, and long-term weight management to address consumers’ needs during rapid fat loss. As the new “appetite economy” takes hold, the Institute of Food Technologists (IFT) highlights that brands are seeking practical strategies to anticipate market changes, enhance product appeal, and maintain regulatory compliance in a dynamic nutrition environment.
